04:51 PM EDT, 03/28/2024 (MT Newswires) -- Brian Elsbernd, Chief Compliance and Legal Officer, on March 27, 2024, sold 25,000 shares in Catalyst Pharmaceuticals ( CPRX ) for $411,000. Following the Form 4 filing with the SEC, Elsbernd has control over a total of 124,433 shares of the company, with 124,433 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1369568/000116169724000164/xslF345X03/form_4.xml

Price: 15.93, Change: -0.01, Percent Change: -0.06